GeNeuro SA is a clinical stage company, which engages in the research and development of pharmaceutical products. It develops treatments against neurological disorders and autoimmune diseases. The firm's lead therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic human endogenous retroviruses (HERV) protein of the W family called pHERV-W env that has been identified as a factor in the onset and development of autoimmune diseases. The company was founded by Herve Perron and Jesus Martin-Garcia in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of GeNeuro SA?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. GeNeuro SA market cap is $113.32M.
What is the 52-week high for GeNeuro SA?
52 week high is the highest price of a stock in the past 52 weeks, or one year. GeNeuro SA 52 week high is $4.55 as of September 06, 2025.
What is the 52-week low for GeNeuro SA?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. GeNeuro SA 52 week low is $4.55 as of September 06, 2025.
What is GeNeuro SA stock price today?
GeNeuro SA stock price today is $4.55.
What was GeNeuro SA stock price yesterday?
GeNeuro SA stock price yesterday was $4.55.
What is the PE ratio of GeNeuro SA?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. GeNeuro SA’s P/E ratio is -10.13.
What is the Price-to-Book ratio of GeNeuro SA?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. GeNeuro SA P/B ratio is 14.2866.
What is the 50-day moving average of GeNeuro SA?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GeNeuro SA 50-day moving average is $4.55.
